CAS: 331-64-6; 2-Fluoro-4-Methoxybenzaldehyde

该化合物是一种芳烃藻,其特点是在苯环上存在氟原子和甲氧基组,该化合物的分子式为C9H9F O2,表明含有9个碳原子,9个氢原子,1个氟原子和2个氧原子.该物质一般是无色的黄色液体,有特殊的芳香味.正丁二甲醚功能组的存在有助于其再活动,使其成为有机合成中的有用中间体,特别是在制药和农用化学品生产中.氟共增强化合物的电益特性,而混合氧组可影响其电子特性和溶解性.2-氟-4-甲基苯氧基苯甲酰胺代丁酯在乙醇和乙醇等有机溶剂中是可溶解的,但水中的溶解性有限.在处理该化合物时,应当采取安全防范措施,因为如果在处理该化合物时可能构成健康风险,如果在处理该化合物时,则可能构成健康风险.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

N-Formylpiperidine 1-fluoro-3-methoxybenzene 2-fluoro-4-hydroxybenzaldehyde methyl iodide 2-fluoro-4-methoxy-benzoic acid E-1,3-bis-(2-fluoro-4-methoxyphenyl)-2-propen-1-one (2-fluoro-4-methoxyphenyl)methanol 1-(2-fluoro-4-methoxyphenyl)acetone

合成工艺路线路线简述

  • 合成目标产物 2-Fluoro-4-Methoxybenzaldehyde 主要起始原料 Pyridine Sulfur Trioxide And 2-Fluoro-4-Methoxybenzyl Alcohol
  • (文献来源)合成步骤主要原料 Pyridine Sulfur Trioxide 和 2-Fluoro-4-Methoxybenzyl Alcohol
N,N-二甲基甲酰胺置于正丁基锂体系中,用 四氢呋喃,正己烷 用作溶剂,化学反应 1.5H,反应生成2-氟-4-甲氧基苯甲醛
参考文献:1-Substituted-3-Beta-D-Glycopyranosylated Nitrogenous Hetero-Cyclic Compounds And Medicines Containing The Same
标题:1-Substituted-3-Beta-D-Glycopyranosylated Nitrogenous Hetero-Cyclic Compounds And Medicines Containing The Same

海关参考信息

专利信息


专利号:US-9796641-B2
优先权日:2013-03-22
标 题:Stabilization of radiosynthetic intermediates
发明人:OTABASHI MUHAMMAD; PHILIPPART GAUTHIER; VOCCIA SAMUEL; WOUTERS LUDOVIC; MORELLE JEAN-LUC
权利人:TRASIS S A
摘要:The present invention relates to a method for stabilizing radiosynthetic intermediates used in synthesis of 18 F radiolabeled aromatic amino acid derivatives toward decomposition caused by beta and gamma radiations by the use of radical scavengers and/or reductants and/or antioxidants.

专利号:US-10793557-B2
优先权日:2018-04-03
标题 :Sting agonist compounds
发明人:ALTMAN MICHAEL D; CASH BRANDON D; CHILDERS MATTHEW LLOYD; CUMMING JARED N; DEMONG DUANE E; HAIDLE ANDREW MARC; HENDERSON TIMOTHY J; JEWELL JAMES P; LARSEN MATTHEW A; LIM JONGWON; LU MIN; OTTE RYAN D; TROTTER BENJAMIN WESLEY
权利人:MERCK SHARP & DOHME
摘要:Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are compositions comprising such compounds, processes for the synthesis of such compounds, and to uses of such compounds, including administration of such compounds to induce immune response, to induce STING-dependent type I interferon production, and/or to treat a cell proliferation disorder, such as cancer.

专利号:US-8633182-B2
优先权日:2012-05-30
标题:Indanyloxyphenylcyclopropanecarboxylic acids
发明人:HAMPRECHT DIETER; FRATTINI SARA; LINGARD IAIN; PETERS STEFAN
权利人:HAMPRECHT DIETER; FRATTINI SARA; LINGARD IAIN; PETERS STEFAN; BOEHRINGER INGELHEIM INT
摘要:The present invention relates to compounds of general formula I, n nwherein the groups R 1 , R 2 , R 3 , m and n are defined as in claim 1 , which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

专利号:US-8927560-B2
优先权日:2010-12-06
标 题 :4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
发明人:AHMED KAMAL; PAIDAKULA SURESH; BANALA ASHWINI KUMAR; ADLA MALLAREDDY; PAPAGARI VENKAT REDDY; JAKI RASHEED TAMBOLI
权利人:AHMED KAMAL; PAIDAKULA SURESH; BANALA ASHWINI KUMAR; ADLA MALLAREDDY; PAPAGARI VENKAT REDDY; JAKI RASHEED TAMBOLI; COUNCIL SCIENT IND RES
摘要:The present invention provides 4-Aza-2,3-didehydropodophyllotoxin compound of general formula A (4a-4z and 4aa-4ae) as useful potential antitumour agents against human cancer cell lines. The present invention further provides a process for the synthesis of 4-Aza-2,3-didehydropodophyllotoxin compounds (4a-4z and 4aa-4ae).

专利号:WO-0050406-A1
优先权日:1999-02-22
标 题 :Isoquinoline derivatives and isoquinoline combinatorial libraries
发明人:LEBL MICHAEL
权利人:TREGA BIOSCIENCES INC
摘要:The present invention provides the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinoline derivatives as well as novel libraries comprised of such compouds.

专利号:US-9423395-B2
优先权日:2013-01-14
标 题:Fluorescent cell cycle probe having M-phase specificity
发明人:CHANG YOUNG-TAE; ZHAI DUANTING; LEE SUNG-CHAN; YUN SEONG-WOOK; JEONG YUN-MI; KANG NAM-YOUNG; PARK SUNG-JIN
权利人:NAT UNIV SINGAPORE; AGENCY SCIENCE TECH & RES
摘要:The present invention is directed to a novel family of fluorophores based on the BODIPY scaffold, and methods for their synthesis. The BODIPY-based fluorophores disclosed herein are used for the selective visualization of cells that exist in the M-phase of the cell cycle. The present invention further relates to methods for the image-based monitoring of mitotic progression in live cells.
阜新奥瑞凯精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.custchem.com.cn
企业联系电话:0418-5113999;18740177324👤
📞阜新奥瑞凯精细化工有限公司 ⚠️参考联系方式
联系人:王经理
电话:0418-5113999;18740177324
手机:18740177324
传真:0418-5113999
邮箱:sales@custchem.com.cn
通信地址: 阜新市海州区氟化学工业园区
邮编: 123000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:阜新市海州区氟化学工业园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Jack G Parsons, Et Al. Chiral Building Blocks: Enantioselective Syntheses Of Benzyloxymethyl Phenyl Propionic Acids. Molecules. 2004 May 31;9(6):449-58.

合成参考文献


摘要:Sapeta, K.; Kerr, M. A., Science of Synthesis Knowledge Updates, (2011) 1, 18.
摘要:Chan, W.-W.; Yu, W.-Y., Science of Synthesis: Catalytic Transformations via CH Activation, (2015) 2, 101.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知